![Jonathan K. Stiles, Ph.D.](/_resources/°ÄÃÅÆßÐÇͼimages/FacultyDirectoryImages/MBI/JonathanStiles_5650.jpg)
Jonathan K. Stiles, Ph.D.
Professor
Microbiology, Biochemistry & Immunology
Location: Hugh Gloster Building
Phone: (404) 752-1585
E-mail: jstiles@msm.edu
Education
GRADUATE:University of Salford
Degree: Doctor of Philosophy
UNDERGRADUATE:
University of Ghana
Degree: Bachelor of Science
Research Interests
Molecular pathogenesis of neglected diseases that affect the central nervous system
(CNS) with emphasis on cerebral malaria and African trypanosomiasis ("Sleeping Sickness")
Our research is focused on three main areas; a) Understanding pathogen-induced brain
encephalopathy, and b) Research and development of anti-parasitic drugs and c) Understanding
immunopathogenesis of Sickle Cell Disease
Pathogen-induced brain neuropathy (Cerebral malaria & African Trypanosomiasis). In
collaboration with the Neuroscience Institute here at °ÄÃÅÆßÐÇͼ, Queens College, NY, University
of Ghana Medical School, and CDC, Atlanta, GA, we are studying the role of cerebral
malaria (CM) and African trypanosomiasis (HAT) in brain neuropathy. Both diseases
impact the central nervous system and result in diffuse encephalopathy in the infected.
The encephalopathy associated with malaria for example is associated with 10-14% of
mortality with an estimated annual death of 1-2.5 million annual deaths globally.
The molecular mechanisms controlling these outcomes are unclear. Current studies ignore
malaria-induced gross neurological defects and the impact of this disease on learning,
cognitive function and neuro-psychology. The absence of effective vaccines or drugs
to protect against these diseases coupled with the increasing drug resistance has
resulted in the re-emergence of malaria and trypanosomiasis in the tropics and subtropics.
We are employing bio-informatics, functional genomics, and proteomics in human and
mouse disease models to study the role of immunomodulators, apoptosis, and signaling
factors in CM and HAT-induced brain pathology.
Research & Development of anti-parasitic drugs. In collaboration with Yale University,
University of Mississippi Medical Center, (UMC), and Noguchi Medical Research Institute
in Ghana, we are targeting cation homeostasis mechanisms of trypanosomes during infection.
Millions of Latin Americans infected with Trypanosoma cruzi (Chagas disease) suffer
chronic splenomegaly, cardiac myopathy and megacolonitis while millions are at risk
of infection with African trypanosomes (HAT) in Africa. HIV infection exacerbates
susceptibility to and further complicates malaria and HAT. Available drugs are very
toxic while supplies are precariously low. We are targeting cation pumps (cation ATPases)
utilized by trypanosomes for uptake of nutrients, as well as for regulating cell volume
and intracellular pH as drug targets. Blocking these ion pumps by specific drugs or
antibodies inhibit proliferation of these parasites in vitro and in their hosts. By
understanding parasite ion homeostasis during infection, we hope that novel strategies
to intervene by drugs may be developed.
Genomics & Immunopathogenesis of Sickle Cell Disease SCD. In collaboration with Drs.
Adamkiewicz, Hibbert, Gee, and Buchanan at °ÄÃÅÆßÐÇͼ, we provide
postdoctoral research training in various aspects of sickle cell disease (SCD) immuno-pathogenesis
in human and murine models. SCD and other hemoglobinopathies are responsible for significant
morbidity and mortality among people of African, Mediterranean and South Asian descent.
Publications
Thompson WE, Pattillo RA, Stiles JK, Schatten G. Biomedical research's unpaid debt: NIH's initiative to support and implement
fairer competition for minority students is a welcome step to redress the exploitation
of African Americans by science. EMBO Rep. 2014 Apr;15(4):333-7. doi: 10.1002/embr.201338274. Epub 2014 Mar 20. PMID: 24652854
Solomon W, Wilson NO, Anderson L, Pitts S, Patrickson J, Liu M, Ford BD, Stiles JK. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria. J Neuroinflammation. 2014 Jan 17;11:9. doi: 10.1186/1742-2094-11-9. PMID: 24433482
Liu M, Wilson NO, Hibbert JM, Stiles JK. STAT3 regulates MMP3 in heme-induced endothelial cell apoptosis. PLoS One. 2013 Aug 13;8(8):e71366. doi: 10.1371/journal.pone.0071366. eCollection 2013. PMID: 23967200
Wilson NO, Solomon W, Anderson L, Patrickson J, Pitts S, Bond V, Liu M, Stiles JK. Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates
mortality associated with murine model of cerebral malaria. PLoS One. 2013 Apr 5;8(4):e60898. doi: 10.1371/journal.pone.0060898. Print 2013. PMID: 23630573
Liu M, Guo S, Stiles JK. The emerging role of CXCL10 in cancer (Review). Oncol Lett. 2011 Jul;2(4):583-589. Epub 2011 May 9. PMID: 22848232
Hyacinth HI, Gee BE, Adamkiewicz TV, Adams RJ, Kutlar A,Stiles JK, Hibbert JM. Plasma BDNF and PDGF-AA levels are associated with high TCD velocity
and stroke in children with sickle cell anemia. Cytokine. 2012 Oct;60(1):302-8. doi: 10.1016/j.cyto.2012.05.017. Epub 2012 Jun 15. Erratum
in: Cytokine. 2013 Apr;62(1):174. PMID: 22704695
Click to view additional publications.